After difficult year, Tecan sees no recovery in early 04
Switzerland's Tecan saw its sales last year fall 6 per cent as turnover growth in its genomics/proteomics division failed to counterbalance declines in drug discovery and diagnostics.
Archives for March 12, 2004
Crucell buys protein production firm
Biotechnology company Crucell has acquired fellow Netherlands-based ChromaGenics in a move to get hold of a promising new technology that could boost yields of proteins and antibodies made in cell culture, writes Phil Taylor.
New drug target for SARS
Researchers in France have isolated the three-dimensional structure of a protein essential for the replication of the virus that causes severe acute respiratory syndrome (SARS) which could represent a new drug target for the disease.
Mobious unveils improved molecular binding test
Mobious Genomics, a UK-based bionanotechnology firm, is to launch a new sensing technique that will allow proteomic, genomic and clinical researchers to conduct protein interaction studies more accurately and with greater sensitivity, writes Wai Lang...
Tool dissects small RNA functions
Since the sequencing of the human genome, there has been a lot of attention paid to finding cellular factors that control gene expression. Micro RNA (miRNA) - small sequences of 20-24 nucleotides that do not code for proteins - are thought to be...